SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019222
Filing Date
2023-05-09
Accepted
2023-05-09 10:00:48
Documents
82
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-20230331.htm   iXBRL 10-Q 2987620
2 EX-10.1 mcrb-ex10_1.htm EX-10 211758
3 EX-31.1 mcrb-ex31_1.htm EX-31 17164
4 EX-31.2 mcrb-ex31_2.htm EX-31 17024
5 EX-32.1 mcrb-ex32_1.htm EX-32 10654
6 EX-32.2 mcrb-ex32_2.htm EX-32 10595
  Complete submission text file 0000950170-23-019222.txt   10828939

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20230331.xsd EX-101.SCH 73581
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mcrb-20230331_cal.xml EX-101.CAL 54996
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20230331_pre.xml EX-101.PRE 419345
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20230331_lab.xml EX-101.LAB 555953
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20230331_def.xml EX-101.DEF 255630
76 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20230331_htm.xml XML 1944215
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 23900503
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences